81 related articles for article (PubMed ID: 8746787)
1. Serum interleukin-6 levels in the steady state of sickle cell disease.
Taylor SC; Shacks SJ; Mitchell RA; Banks A
J Interferon Cytokine Res; 1995 Dec; 15(12):1061-4. PubMed ID: 8746787
[TBL] [Abstract][Full Text] [Related]
2. Type 2 cytokine serum levels in healthy sickle cell disease patients.
Taylor SC; Shacks SJ; Qu Z; Wiley P
J Natl Med Assoc; 1997 Nov; 89(11):753-7. PubMed ID: 9375480
[TBL] [Abstract][Full Text] [Related]
3. In vivo production of type 1 cytokines in healthy sickle cell disease patients.
Taylor SC; Shacks SJ; Qu Z
J Natl Med Assoc; 1999 Nov; 91(11):619-24. PubMed ID: 10641497
[TBL] [Abstract][Full Text] [Related]
4. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition.
Sarray S; Saleh LR; Lisa Saldanha F; Al-Habboubi HH; Mahdi N; Almawi WY
Cytokine; 2015 Mar; 72(1):43-7. PubMed ID: 25569375
[TBL] [Abstract][Full Text] [Related]
5. Alpha-2-macroglobulin and interleukin-6 levels in steady-state sickle cell disease patients.
Makis AC; Hatzimichael EC; Mavridis A; Bourantas KL
Acta Haematol; 2000; 104(4):164-8. PubMed ID: 11279305
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-IL-6 and anti-10 monoclonal antibodies on the suppression of the normal T lymphocyte mitogenic response by steady state sickle cell disease sera.
Taylor S; Shacks S; Qu Z
Immunol Invest; 2001 Aug; 30(3):209-19. PubMed ID: 11570641
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of reticulated platelets in patients with sickle cell diseases.
Noronha JF; Costa FF; Saad ST; Lorand-Metze IG; Grotto HZ
Thromb Res; 2007; 121(2):259-67. PubMed ID: 17521711
[TBL] [Abstract][Full Text] [Related]
8. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
9. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
10. Interferon production in sickle cell disease.
Taylor SC; Shacks SJ; Villicana SM; Olivares J; Dinkins GA
Lymphokine Res; 1990; 9(3):415-23. PubMed ID: 1697921
[TBL] [Abstract][Full Text] [Related]
11. Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition.
Keikhaei B; Mohseni AR; Norouzirad R; Alinejadi M; Ghanbari S; Shiravi F; Solgi G
Eur Cytokine Netw; 2013 Mar; 24(1):45-52. PubMed ID: 23608554
[TBL] [Abstract][Full Text] [Related]
12. Plasma protein C levels in children with sickle cell disease.
Karayalcin G; Lanzkowsky P
Am J Pediatr Hematol Oncol; 1989; 11(3):320-3. PubMed ID: 2782560
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
14. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids.
Setty BN; Chen D; Stuart MJ
Pediatr Res; 1995 Jul; 38(1):95-102. PubMed ID: 7478805
[TBL] [Abstract][Full Text] [Related]
15. [Lipid, lipoproteins and atherogenesis profiles in sickle cell disease among Central African patients].
Mokondjimobe E; Longo-Mbenza B; Ovono-Abessolo F; Gombet T; Guie G; Ngou-Milama E; Parra HJ
Ann Biol Clin (Paris); 2012; 70(2):183-8. PubMed ID: 22484529
[TBL] [Abstract][Full Text] [Related]
16. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.
Noubouossie DF; Lê PQ; Corazza F; Debaugnies F; Rozen L; Ferster A; Demulder A
Am J Hematol; 2012 Feb; 87(2):145-9. PubMed ID: 22052675
[TBL] [Abstract][Full Text] [Related]
17. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case-control study.
Rincón-López EM; Navarro Gómez ML; Hernández-Sampelayo Matos T; Aguilera-Alonso D; Dueñas Moreno E; Saavedra-Lozano J; Santiago García B; Santos Sebastián MDM; García Morín M; Beléndez Bieler C; Lorente Romero J; Cela de Julián E;
BMC Infect Dis; 2021 Aug; 21(1):741. PubMed ID: 34344349
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the expression of red blood cell CD36, interleukin-6 and interleukin-8 in sickle cell anemia pediatric patients.
Abdul-Hussein HK; Al-Mammori HS; Hassan MK
Cytokine; 2021 Jul; 143():155534. PubMed ID: 33888402
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha and IL-8: serum levels and gene polymorphisms (-308G>A and -251A>T) are associated with classical biomarkers and medical history in children with sickle cell anemia.
Cajado C; Cerqueira BA; Couto FD; Moura-Neto JP; Vilas-Boas W; Dorea MJ; Lyra IM; Barbosa CG; Reis MG; Goncalves MS
Cytokine; 2011 Nov; 56(2):312-7. PubMed ID: 21802960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
